Families with MSH6 mutations have been reported to have a lower incidence of colorectal cancer (CRC) and later age of disease onset than MLH1 and MSH2 families [20], while others suggest same high lifetime risk of CRC and later age of disease onset [15,29]. This evidence concerns the gene MLH1 and colorectal carcinoma.